Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361949905> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4361949905 abstract "<div>Abstract<p><b>Purpose:</b> P-glycoprotein (Pgp) antagonists have been difficult to develop because of complex pharmacokinetic interactions and a failure to show meaningful results. Here we report the results of a pharmacokinetic and pharmacodynamic trial using a third-generation, potent, noncompetitive inhibitor of Pgp, tariquidar (XR9576), in combination with docetaxel.</p><p><b>Experimental Design:</b> In the first treatment cycle, the pharmacokinetics of docetaxel (40 mg/m<sup>2</sup>) were evaluated after day 1 and day 8 doses, which were administered with or without tariquidar (150 mg). <sup>99m</sup>Tc-sestamibi scanning and CD56<sup>+</sup> mononuclear cell rhodamine efflux assays were conducted to assess Pgp inhibition. In subsequent cycles, 75 mg/m<sup>2</sup> docetaxel was administered with 150 mg tariquidar every 3 weeks.</p><p><b>Results:</b> Forty-eight patients were enrolled onto the trial. Nonhematologic grade 3/4 toxicities in 235 cycles were minimal. Tariquidar inhibited Pgp-mediated rhodamine efflux from CD56<sup>+</sup> cells and reduced <sup>99m</sup>Tc-sestamibi clearance from the liver. There was striking variability in basal sestamibi uptake; a 12% to 24% increase in visible lesions was noted in 8 of 10 patients with lung cancer. No significant difference in docetaxel disposition was observed in pairwise comparison with and without tariquidar. Four partial responses (PR) were seen (4/48); 3 in the non–small cell lung cancer (NSCLC) cohort, measuring 40%, 57%, and 67% by RECIST, and 1 PR in a patient with ovarian cancer.</p><p><b>Conclusions:</b> Tariquidar is well tolerated, with less observed systemic pharmacokinetic interaction than previous Pgp antagonists. Variable effects of tariquidar on retention of sestamibi in imageable lung cancers suggest that follow-up studies assessing tumor drug uptake in this patient population would be worthwhile. <i>Clin Cancer Res; 17(3); 569–80. ©2010 AACR</i>.</p></div>" @default.
- W4361949905 created "2023-04-05" @default.
- W4361949905 creator A5006092876 @default.
- W4361949905 creator A5013592290 @default.
- W4361949905 creator A5021627028 @default.
- W4361949905 creator A5024249524 @default.
- W4361949905 creator A5027394799 @default.
- W4361949905 creator A5044239219 @default.
- W4361949905 creator A5046042179 @default.
- W4361949905 creator A5047017840 @default.
- W4361949905 creator A5059886787 @default.
- W4361949905 creator A5062005062 @default.
- W4361949905 creator A5064625461 @default.
- W4361949905 creator A5065220600 @default.
- W4361949905 creator A5070972780 @default.
- W4361949905 date "2023-03-31" @default.
- W4361949905 modified "2023-10-16" @default.
- W4361949905 title "Data from A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer" @default.
- W4361949905 doi "https://doi.org/10.1158/1078-0432.c.6519969.v1" @default.
- W4361949905 hasPublicationYear "2023" @default.
- W4361949905 type Work @default.
- W4361949905 citedByCount "0" @default.
- W4361949905 crossrefType "posted-content" @default.
- W4361949905 hasAuthorship W4361949905A5006092876 @default.
- W4361949905 hasAuthorship W4361949905A5013592290 @default.
- W4361949905 hasAuthorship W4361949905A5021627028 @default.
- W4361949905 hasAuthorship W4361949905A5024249524 @default.
- W4361949905 hasAuthorship W4361949905A5027394799 @default.
- W4361949905 hasAuthorship W4361949905A5044239219 @default.
- W4361949905 hasAuthorship W4361949905A5046042179 @default.
- W4361949905 hasAuthorship W4361949905A5047017840 @default.
- W4361949905 hasAuthorship W4361949905A5059886787 @default.
- W4361949905 hasAuthorship W4361949905A5062005062 @default.
- W4361949905 hasAuthorship W4361949905A5064625461 @default.
- W4361949905 hasAuthorship W4361949905A5065220600 @default.
- W4361949905 hasAuthorship W4361949905A5070972780 @default.
- W4361949905 hasBestOaLocation W43619499052 @default.
- W4361949905 hasConcept C111113717 @default.
- W4361949905 hasConcept C112705442 @default.
- W4361949905 hasConcept C121608353 @default.
- W4361949905 hasConcept C126322002 @default.
- W4361949905 hasConcept C133936738 @default.
- W4361949905 hasConcept C185592680 @default.
- W4361949905 hasConcept C2778707650 @default.
- W4361949905 hasConcept C2781190966 @default.
- W4361949905 hasConcept C501593827 @default.
- W4361949905 hasConcept C55493867 @default.
- W4361949905 hasConcept C71924100 @default.
- W4361949905 hasConcept C98274493 @default.
- W4361949905 hasConceptScore W4361949905C111113717 @default.
- W4361949905 hasConceptScore W4361949905C112705442 @default.
- W4361949905 hasConceptScore W4361949905C121608353 @default.
- W4361949905 hasConceptScore W4361949905C126322002 @default.
- W4361949905 hasConceptScore W4361949905C133936738 @default.
- W4361949905 hasConceptScore W4361949905C185592680 @default.
- W4361949905 hasConceptScore W4361949905C2778707650 @default.
- W4361949905 hasConceptScore W4361949905C2781190966 @default.
- W4361949905 hasConceptScore W4361949905C501593827 @default.
- W4361949905 hasConceptScore W4361949905C55493867 @default.
- W4361949905 hasConceptScore W4361949905C71924100 @default.
- W4361949905 hasConceptScore W4361949905C98274493 @default.
- W4361949905 hasLocation W43619499051 @default.
- W4361949905 hasLocation W43619499052 @default.
- W4361949905 hasOpenAccess W4361949905 @default.
- W4361949905 hasPrimaryLocation W43619499051 @default.
- W4361949905 hasRelatedWork W2004439498 @default.
- W4361949905 hasRelatedWork W2006243213 @default.
- W4361949905 hasRelatedWork W2021250530 @default.
- W4361949905 hasRelatedWork W2053883508 @default.
- W4361949905 hasRelatedWork W2065508314 @default.
- W4361949905 hasRelatedWork W2095019580 @default.
- W4361949905 hasRelatedWork W2098023573 @default.
- W4361949905 hasRelatedWork W2524098531 @default.
- W4361949905 hasRelatedWork W3135096959 @default.
- W4361949905 hasRelatedWork W589099824 @default.
- W4361949905 isParatext "false" @default.
- W4361949905 isRetracted "false" @default.
- W4361949905 workType "article" @default.